Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: A review of new avenues in its management

68Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Temporal lobe necrosis (TLN) is the most debilitating late-stage complication after radiation therapy in patients with nasopharyngeal cancer (NPC). The bilateral temporal lobes are inevitably encompassed in the radiation field and are thus prone to radiation induced necrosis. The wide use of 3D conformal and intensity-modulated radiation therapy (IMRT) in the treatment of NPC has led to a dwindling incidence of TLN. Yet, it still holds great significance due to its incapacitating feature and the difficulties faced clinically and radiologically in distinguishing it from a malignancy. In this review, we highlight the evolution of different imaging modalities and therapeutic options. FDG PET, SPECT and Magnetic Spectroscopy are among the latest imaging tools that have been considered. In terms of treatment, Bevacizumab remains the latest promising breakthrough due to its ability to reverse the pathogenesis unlike conventional treatment options including large doses of steroids, anticoagulants, vitamins, hyperbaric oxygen and surgery. © 2011 Chen et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Chen, J., Dassarath, M., Yin, Z., Liu, H., Yang, K., & Wu, G. (2011, September 30). Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: A review of new avenues in its management. Radiation Oncology. https://doi.org/10.1186/1748-717X-6-128

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free